Literature DB >> 20404374

Ferric carboxymaltose improved symptoms and quality of life in patients with chronic heart failure and iron deficiency.

Robb D Kociol1, L Kristin Newby.   

Abstract

Entities:  

Year:  2010        PMID： 20404374     DOI： 10.7326/0003-4819-152-8-201004200-02005

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  1 in total

1.  Cost-minimization analysis favours intravenous ferric carboxymaltose over ferric sucrose for the ambulatory treatment of severe iron deficiency.

Authors:  Xavier Calvet; Miquel Àngel Ruíz; Angelina Dosal; Laura Moreno; Maria López; Ariadna Figuerola; David Suarez; Mireia Miquel; Albert Villoria; Emili Gené
Journal:  PLoS One       Date:  2012-09-21       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.